Nov 6, 2025 08:00AM
Aug 14, 2025 08:00AM
Jul 30, 2025 08:01AM
Jul 30, 2025 08:00AM
May 8, 2025 04:28PM
May 8, 2025 08:00AM
Mar 6, 2025 08:00AM VYNE Therapeutics Reports 2024 Fourth Quarter and Year-End Financial Results and Provides Business Update
Nov 7, 2024 08:00AM
Aug 15, 2024 06:09AM
Aug 14, 2024 08:00AM
May 9, 2024 08:00AM
Feb 29, 2024 08:00AM
Nov 13, 2023 07:45AM
Aug 14, 2023 08:00AM VYNE Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Update
May 11, 2023 05:28PM
May 11, 2023 04:01PM
Mar 9, 2023 04:01PM
Nov 10, 2022 05:12PM
Nov 10, 2022 04:01PM
Aug 12, 2022 08:00AM
May 13, 2022 06:27AM Cantor Fitzgerald Reiterates VYNE Therapeutics (VYNE) at Overweight with $10 Price Target, Expects "Upwards Earnings Estimate Revisions and Multiple Expansion"
May 12, 2022 04:05PM
Mar 17, 2022 10:55AM
Mar 17, 2022 08:00AM
Nov 10, 2021 01:31PM
Nov 10, 2021 07:30AM
Oct 28, 2021 08:00AM
Aug 12, 2021 07:30AM VYNE Therapeutics Reports Second Quarter 2021 Financial Results and Announces New Strategic Direction to Develop Treatments for Immunological and Inflammatory Diseases
Aug 12, 2021 07:00AM
Jul 27, 2021 08:00AM
May 6, 2021 07:00AM
Apr 28, 2021 08:00AM
Mar 4, 2021 07:00AM
Mar 1, 2021 08:10AM
Mar 1, 2021 08:00AM VYNE Therapeutics Announces Development Program for FMX114 Combination Topical Gel for Mild-to-Moderate Atopic Dermatitis
Feb 23, 2021 08:00AM
Nov 5, 2020 07:00AM
Oct 28, 2020 08:00AM

1,197,259 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All